Skip to content

Chairside Mouthrinse Test and Cost Effectiveness

Pilot Study on Oral Health Status Chairside Mouthrinse Test in Finnish Adolescents and Cost Effectiveness of the Test

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04139863
Acronym
JuvePar
Enrollment
200
Registered
2019-10-25
Start date
2017-09-01
Completion date
2020-11-02
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Juvenile

Brief summary

The aim is to study whether participants at risk could be identified using an aMMP-8 chairside mouth rinse test and to study if oral health and health behaviour is linked to the test result in Finnish adolescents.

Detailed description

Adolescents (14-15-year-olds) are randomly divided to control group and test group. Chairside mouth rinse test for aMMP-8 is performed for the test group. Two groups are compared with each other. Participants are asked to fill a questionnaire which consists of questions concerning oral hygiene habits, tobacco products, alcohol, drug and snuff use.

Interventions

DIAGNOSTIC_TESTaMMP-8 chairside test

No test

Sponsors

University of Helsinki
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* All 8 class (aged 14-15 years) pupils in Jukola, Hämeenlinna, Finland * Written informed consent from the participants and their parents (one of them)

Exclusion criteria

* No written consent to the study

Design outcomes

Primary

MeasureTime frameDescription
aMMP-8 test1 yearMouth rinse samples are analysed by method for chair-side diagnostic testing: the aMMP-8 specific lateral-flow point-of-care (PoC)/chair-side test (PerioSafe®, Dentognostics GmbH, Jena, Germany). The result is provided in 5 minutes and is graded by eye as positive or negative. One line means that the test is negative but successfully done and two lines the test is positive.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026